Well-Ordered Au Nanoarray for Sensitive and Reproducible Detection of Hepatocellular Carcinoma-Associated miRNA via CHA-Assisted SERS/Fluorescence Dual-Mode Sensing

• Published in: Analytical chemistry (Washington) Vol. 95; no. 14; pp. 5955 - 5966
• Main Authors: Huang, Xueqin, Tian, Hemi, Huang, Lei, Chen, Qiuxia, Yang, Yingqi, Zeng, Runmin, Xu, Jun, Chen, Shanze, Zhou, Xia, Liu, Guangqiang, Li, Haoyu, Zhang, Yuan, Zhang, Jianglin, Zheng, Junxia, Cai, Huaihong, Zhou, Haibo
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 11-04-2023
• Subjects: Biomarkers; Biosensing Techniques; Biosensors; Cancer; Carcinoma, Hepatocellular - diagnosis; Chemistry; Fluorescence; Fluorescent Dyes - chemistry; Gold; Gold - chemistry; Hepatectomy; Hepatocellular carcinoma; Humans; Interference; Limit of Detection; Liver cancer; Liver Neoplasms - diagnosis; Metal Nanoparticles - chemistry; MicroRNAs; miRNA; Nanostructures; Raman spectra; Reproducibility; Reproducibility of Results; Spectrum Analysis, Raman; Substrates; Target detection
• ISSN: 0003-2700; 1520-6882
• DOI: 10.1021/acs.analchem.2c05640

Ultra-sensitive detection of cancer-related biomarkers in serum is of great significance for early diagnosis, treatment, prognosis, and staging of cancer. In this work, we proposed a surface-enhanced Raman scattering and fluorescence (SERS/FL) dual-mode biosensor for hepatocellular carcinoma (HCC)-related miRNA (miR-224) detection using the composition of well-arranged Au nanoarrays (Au NAs) substrate coupled with the target-catalyzed hairpin assembly (CHA) strategy. The hot spots densely and uniformly distributed on the Au array offers considerably enhanced and reproducible SERS signals, along with their wide and open surface to facilitate miR-224 adsorption. By this sensing strategy, the target miR-224 can be detected in a wide linear range (1 fM to 1 nM) with a limit of detection of 0.34 fM in the SERS mode and 0.39 fM in the FL mode. Meanwhile, this biosensor with exceptional specificity and anti-interference ability can discriminate target miR-224 from other interference miRNAs. Practical analysis of human blood samples also demonstrated considerable reliability and repeatability of our developed strategy. Furthermore, this biosensor can distinguish HCC cancer subjects from normal ones and monitor HCC patients before and after hepatectomy as well as guide the distinct Barcelona clinic liver cancer (BCLC) stages. Overall, benefiting from a well-arranged Au nanoarray, CHA amplification strategy, and SERS/metal enhanced fluorescence effect, this established biosensor opens new avenues for the early prediction, warning, monitoring, and staging of HCC.